
Phu Hoang Nguyen
Examiner (ID: 14741, Phone: (571)272-5931 , Office: P/1747 )
| Most Active Art Unit | 1747 |
| Art Unit(s) | 1731, 1747, 1791 |
| Total Applications | 942 |
| Issued Applications | 511 |
| Pending Applications | 112 |
| Abandoned Applications | 343 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19164754
[patent_doc_number] => 11980636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Treatment of hematological disorders
[patent_app_type] => utility
[patent_app_number] => 17/530245
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 42
[patent_no_of_words] => 15098
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/530245 | Treatment of hematological disorders | Nov 17, 2021 | Issued |
Array
(
[id] => 18861830
[patent_doc_number] => 20230416265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOUNDS FOR THE DETECTION OF HEME OXYGENASE 1 (HO-1), AND METHODS AND USES INVOLVING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/252597
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252597
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252597 | COMPOUNDS FOR THE DETECTION OF HEME OXYGENASE 1 (HO-1), AND METHODS AND USES INVOLVING THE SAME | Nov 11, 2021 | Pending |
Array
(
[id] => 18842517
[patent_doc_number] => 20230404921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/250942
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250942
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250942 | LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE | Oct 28, 2021 | Pending |
Array
(
[id] => 18830853
[patent_doc_number] => 20230399378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PEPTIDE-BASED DELIVERY OF AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/034526
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034526 | PEPTIDE-BASED DELIVERY OF AGENTS | Oct 27, 2021 | Pending |
Array
(
[id] => 17532389
[patent_doc_number] => 20220110998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ESSENTIAL OIL EMULSION NOSTRIL TREATMENT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/512306
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512306 | Essential oil emulsion nostril treatment composition | Oct 26, 2021 | Issued |
Array
(
[id] => 18818813
[patent_doc_number] => 20230393153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => DIAGNOSTIC AND THERAPY OF TRAUMATIC BRAIN INJURY
[patent_app_type] => utility
[patent_app_number] => 18/033029
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033029 | DIAGNOSTIC AND THERAPY OF TRAUMATIC BRAIN INJURY | Oct 21, 2021 | Pending |
Array
(
[id] => 18842751
[patent_doc_number] => 20230405155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG
[patent_app_type] => utility
[patent_app_number] => 18/034108
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034108 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | Oct 19, 2021 | Pending |
Array
(
[id] => 17519183
[patent_doc_number] => 20220105031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHOD FOR ADMINISTERING LIPOSOMAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/505119
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505119 | Method for administering liposomal composition | Oct 18, 2021 | Issued |
Array
(
[id] => 18226916
[patent_doc_number] => 20230065910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => NANO-ARMORED SINGLE CELL PRODUCT FOR TREATING PARKINSON'S DISEASE THROUGH BACTERIA AND A PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/503561
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503561
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503561 | Nano-armored single cell product for treating Parkinson's disease through bacteria and a preparation method thereof | Oct 17, 2021 | Issued |
Array
(
[id] => 17761765
[patent_doc_number] => 20220235377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => METHODS OF LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/500491
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500491 | Methods of lipid nanoparticle manufacture and compositions derived therefrom | Oct 12, 2021 | Issued |
Array
(
[id] => 19622947
[patent_doc_number] => 12161739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Peroxymonosulfate toothpowder composition for tenacious stains
[patent_app_type] => utility
[patent_app_number] => 17/497503
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6357
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497503 | Peroxymonosulfate toothpowder composition for tenacious stains | Oct 7, 2021 | Issued |
Array
(
[id] => 18707690
[patent_doc_number] => 20230330272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 18/023360
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023360 | COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME | Oct 4, 2021 | Pending |
Array
(
[id] => 17355239
[patent_doc_number] => 20220016035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Extended Release Highly Loaded Drug Compositions
[patent_app_type] => utility
[patent_app_number] => 17/489137
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489137 | Extended Release Highly Loaded Drug Compositions | Sep 28, 2021 | Pending |
Array
(
[id] => 19716208
[patent_doc_number] => 12201724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Lecithin vesicles for oral delivery
[patent_app_type] => utility
[patent_app_number] => 17/483129
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 11112
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483129 | Lecithin vesicles for oral delivery | Sep 22, 2021 | Issued |
Array
(
[id] => 19439998
[patent_doc_number] => 12090225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Specially formulated compositions of inhaled nintedanib and nintedanib salts
[patent_app_type] => utility
[patent_app_number] => 17/469594
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58702
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/469594 | Specially formulated compositions of inhaled nintedanib and nintedanib salts | Sep 7, 2021 | Issued |
Array
(
[id] => 18691058
[patent_doc_number] => 20230321251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT
[patent_app_type] => utility
[patent_app_number] => 18/024459
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024459 | LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT | Sep 2, 2021 | Pending |
Array
(
[id] => 18581562
[patent_doc_number] => 20230263814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/024040
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -97
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024040
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024040 | METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS | Aug 29, 2021 | Abandoned |
Array
(
[id] => 19195334
[patent_doc_number] => 11992553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Inhalable powder formulations of alginate oligomers
[patent_app_type] => utility
[patent_app_number] => 17/445577
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 18424
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445577 | Inhalable powder formulations of alginate oligomers | Aug 19, 2021 | Issued |
Array
(
[id] => 18656260
[patent_doc_number] => 20230302154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/041811
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041811
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041811 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | Aug 18, 2021 | Pending |
Array
(
[id] => 18724353
[patent_doc_number] => 20230338495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => Vaccine Compositions and Antibodies For Lyme Disease
[patent_app_type] => utility
[patent_app_number] => 18/022087
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022087
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022087 | Vaccine Compositions and Antibodies For Lyme Disease | Aug 18, 2021 | Pending |